[
  {
    "ts": null,
    "headline": "Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump",
    "summary": "Metsera stock surged Monday after the drugmaker unveiled \"solid\" results for a potential monthly shot to stoke weight loss.",
    "url": "https://finnhub.io/api/news?id=35575afd26af976339d157202acef7fda481a7d3e4f131c56b304544a7906885",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749483859,
      "headline": "Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump",
      "id": 135134600,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Metsera stock surged Monday after the drugmaker unveiled \"solid\" results for a potential monthly shot to stoke weight loss.",
      "url": "https://finnhub.io/api/news?id=35575afd26af976339d157202acef7fda481a7d3e4f131c56b304544a7906885"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)’s share was trading at $765.68 as of 5th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance. Eli […]",
    "url": "https://finnhub.io/api/news?id=823d148384301f651547fcf780cf8fcb34789e5335bca7a8ada476712ad5c9e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749485145,
      "headline": "Eli Lilly and Company (LLY): A Bull Case Theory",
      "id": 135140932,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company (LLY)’s share was trading at $765.68 as of 5th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance. Eli […]",
      "url": "https://finnhub.io/api/news?id=823d148384301f651547fcf780cf8fcb34789e5335bca7a8ada476712ad5c9e7"
    }
  },
  {
    "ts": null,
    "headline": "Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?",
    "summary": "We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that Jim Cramer discusses. Back then, a humorous caller asked if they should “bulk up” on Viking Therapeutics, Inc. (NASDAQ:VKTX), referencing both […]",
    "url": "https://finnhub.io/api/news?id=003237eb0ed469619d12e99a784c7d70ef9b3ef94dd15445d42fe262add076b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749479241,
      "headline": "Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?",
      "id": 135128906,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that Jim Cramer discusses. Back then, a humorous caller asked if they should “bulk up” on Viking Therapeutics, Inc. (NASDAQ:VKTX), referencing both […]",
      "url": "https://finnhub.io/api/news?id=003237eb0ed469619d12e99a784c7d70ef9b3ef94dd15445d42fe262add076b3"
    }
  },
  {
    "ts": null,
    "headline": "Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch",
    "summary": "Metsera stock surged Monday after the drugmaker unveiled \"solid\" results for a potential monthly shot to stoke weight loss.",
    "url": "https://finnhub.io/api/news?id=59b546e174f32b1e30518debe120ec9fb88d0c4788cd5f61da428093f235a5c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749476582,
      "headline": "Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch",
      "id": 135124766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Metsera stock surged Monday after the drugmaker unveiled \"solid\" results for a potential monthly shot to stoke weight loss.",
      "url": "https://finnhub.io/api/news?id=59b546e174f32b1e30518debe120ec9fb88d0c4788cd5f61da428093f235a5c7"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=3ebdda86a56120665315183525b7bbcf03ceb4139e7a7ca364049fb5d7e1bda3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749474014,
      "headline": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 135130328,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=3ebdda86a56120665315183525b7bbcf03ceb4139e7a7ca364049fb5d7e1bda3"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy",
    "summary": "Chugai Pharmaceutical Co. Ltd. (OTC:CHGCY) believes its anti-muscle-wasting drug could be used alongside Eli Lilly And Co.’s (NYSE:LLY) oral obesity pill, orforglipron. Roche Holdings AG (OTC:RHHBY) is a major shareholder of Chugai, a Japanese pharmaceutical company. The company’s optimism stems from growing evidence that modern weight-loss drugs can lead to significant muscle loss, an issue Chugai thinks it can help address. Hitoshi Iikura, a senior executive at Chugai, told the Financial Times",
    "url": "https://finnhub.io/api/news?id=8427d3280381f519e57358664fb466cebf5e924a5eea28d053fe1431cc733645",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749471114,
      "headline": "Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy",
      "id": 135124768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Chugai Pharmaceutical Co. Ltd. (OTC:CHGCY) believes its anti-muscle-wasting drug could be used alongside Eli Lilly And Co.’s (NYSE:LLY) oral obesity pill, orforglipron. Roche Holdings AG (OTC:RHHBY) is a major shareholder of Chugai, a Japanese pharmaceutical company. The company’s optimism stems from growing evidence that modern weight-loss drugs can lead to significant muscle loss, an issue Chugai thinks it can help address. Hitoshi Iikura, a senior executive at Chugai, told the Financial Times",
      "url": "https://finnhub.io/api/news?id=8427d3280381f519e57358664fb466cebf5e924a5eea28d053fe1431cc733645"
    }
  },
  {
    "ts": null,
    "headline": "5 Monster Stocks to Hold for the Next 10 Years",
    "summary": "TSMC is set to benefit from the continued growth in AI infrastructure and semiconductors in general.  Pinterest is harnessing the power of AI to better monetize its large user base.  Dutch Bros has one of the best expansion stories in the restaurant space.",
    "url": "https://finnhub.io/api/news?id=14ad7de8e94a2c119aa737685a4e5678cb2ce5ecb2333f6d57ff2bde58aa7351",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749457500,
      "headline": "5 Monster Stocks to Hold for the Next 10 Years",
      "id": 135123306,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "TSMC is set to benefit from the continued growth in AI infrastructure and semiconductors in general.  Pinterest is harnessing the power of AI to better monetize its large user base.  Dutch Bros has one of the best expansion stories in the restaurant space.",
      "url": "https://finnhub.io/api/news?id=14ad7de8e94a2c119aa737685a4e5678cb2ce5ecb2333f6d57ff2bde58aa7351"
    }
  },
  {
    "ts": null,
    "headline": "The biggest obesity deals of 2025 so far",
    "summary": "Three pharma giants are snapping up new assets to find stronger footing in the quickly shifting weight loss market.",
    "url": "https://finnhub.io/api/news?id=ecc8b0903144e9a58978844d05c4a044fa8a9145f3d920a6b5e2b1b8f314756a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749456000,
      "headline": "The biggest obesity deals of 2025 so far",
      "id": 135124771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Three pharma giants are snapping up new assets to find stronger footing in the quickly shifting weight loss market.",
      "url": "https://finnhub.io/api/news?id=ecc8b0903144e9a58978844d05c4a044fa8a9145f3d920a6b5e2b1b8f314756a"
    }
  }
]